Day: June 2, 2021

Fusion Acquisition Corp. II Receives NYSE Notice Regarding Delayed Form 10-Q Filing

Written by Customer Service on June 2, 2021. Posted in Public Companies.

NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) — Fusion Acquisition Corp. II (NYSE: FSNB) (the “Company”) today announced that it received a notice from the New York Stock Exchange (the “NYSE”) indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Q1 2021 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The notice has no immediate effect on the listing of the Company’s stock on the NYSE. The NYSE informed the Company that, under the NYSE’s rules, the Company can regain compliance with the NYSE’s continued listing requirements by filing the Q1 2021 Form 10-Q with the SEC at any time prior to November 24, 2021. As the Company reported in its Form 12b-25...

Dyne Therapeutics Announces Chief Scientific Officer Transition

Written by Customer Service on June 2, 2021. Posted in Public Companies.

– Co-founder Romesh Subramanian, Ph.D., stepping down as chief scientific officer and will serve as an advisor after leading successful R&D and pipeline-building efforts – – Oxana Beskrovnaya, Ph.D., appointed CSO – WALTHAM, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that Romesh Subramanian, Ph.D. has chosen to step down as chief scientific officer for personal reasons and will continue to serve as an advisor to Dyne. Concurrently, Oxana Beskrovnaya, Ph.D., who has served as Dyne’s senior vice president, head of research since January 2020, has been appointed CSO. “In co-founding Dyne, Romesh laid the foundation...

Pool Corporation to Present at the Baird 2021 Virtual Global Consumer, Technology & Services Conference

Written by Customer Service on June 2, 2021. Posted in Public Companies.

COVINGTON, La., June 02, 2021 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq:POOL) announced today that Peter D. Arvan, President and Chief Executive Officer, and Mark W. Joslin, Senior Vice President and Chief Financial Officer, will be participating in the Baird 2021 Virtual Global Consumer, Technology & Services Conference. The general session will occur on Wednesday, June 9, 2021, at 9:40 AM Eastern Time and will be in a ‘fireside chat’ format consisting of a short presentation followed by Q&A. Informational materials used during the conference will be posted on POOLCORP’s website on the morning of the conference. Pool Corporation is the world’s largest wholesale distributor of swimming pool and related backyard products. POOLCORP operates approximately 400 sales centers in North America, Europe and Australia through...

MedTech Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Written by Customer Service on June 2, 2021. Posted in Public Companies.

New York, NY, June 02, 2021 (GLOBE NEWSWIRE) — MedTech Acquisition Corporation (Nasdaq: MTACU) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq’s continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission (the “SEC”) on May 17, 2021, the Company was unable to file its Form 10-Q within the prescribed time period without unreasonable effort or expense. The extension...

nCino Reports First Quarter Fiscal Year 2022 Financial Results

Written by Customer Service on June 2, 2021. Posted in Earnings Releases And Operating Results.

First Quarter Total Revenues of $62.4M, up 39% year-over-year First Quarter Subscription Revenues of $51.0M, up 47% year-over-year WILMINGTON, N.C., June 02, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced financial results for its first quarter of fiscal year 2022 ended April 30, 2021. “We are very pleased with the strong start to the year, reflecting a solid sales quarter and ending with yet another record pipeline for the Company,” said Pierre Naudé, CEO of nCino. “We saw particular strength internationally, including signing our first German bank, as well as closing a commercial deal with one of Canada’s top five banks. In addition to our strong sales momentum, we continued to innovate this quarter...

Descartes Announces Fiscal 2022 First Quarter Financial Results

Written by Customer Service on June 2, 2021. Posted in Earnings Releases And Operating Results.

Record Revenues and Income from Operations WATERLOO, Ontario, June 02, 2021 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2022 first quarter (Q1FY22). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP). “We believe that by helping our customers succeed, Descartes will succeed. The financial results we’ve reported today reflect that,” said Edward J. Ryan, Descartes’ CEO. “Our customers face complex multi-party, multi-process supply chain and logistics challenges. This is even more so in recent times where our customers have faced rapid changes in supply, demand and trade regulations. Our Global Logistics Network is designed...

Align Technology Awards Funding to Universities Worldwide to Advance Orthodontic and Dental Research

Written by Customer Service on June 2, 2021. Posted in Public Companies.

$250,000 in Research Grants Awarded as Part of Annual Research Awards Program TEMPE, Ariz., June 02, 2021 (GLOBE NEWSWIRE) — Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of ten research grants under the company’s eleventh Annual Research Award Program. The global interest in research to advance dental and orthodontic treatments continues to grow as evidenced by the increasing number of applications Align Technology receives each year from universities around the world. Since the program’s inception in 2010, Align has funded over $2.0 million in research awards that have led to advancements...

Kymera Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

Written by Customer Service on June 2, 2021. Posted in Public Companies.

WATERTOWN, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9 at 4:40 p.m. ET. A live webcast of the event will be available under “Events and Presentations” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available for one month following the event. About Kymera TherapeuticsKymera Therapeutics (Nasdaq: KYMR) is a clinical-stage biopharmaceutical company founded with the mission to discover, develop, and commercialize...

LIDDS carry out a directed share issue of and is provided with approximately MSEK 45

Written by Customer Service on June 2, 2021. Posted in Public Companies.

NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE IN VIOLATION OF APPLICABLE RULES OR REQUIRE REGISTRATION OR OTHER MEASURES. The Board of Directors of LIDDS AB (“LIDDS” or the “Company”) has, in accordance with the press release issued by the Company on 27 May 2021 and based on the authorization from the Annual General Meeting on 17 May 2021, resolved on a directed new issue of 4,314,475 shares by payment in cash to a limited number of investors (the “Share Issue”), and hereby the Company will be provided with approximately 45 MSEK before issue costs. The subscription price in the Share Issue was determined...

Cytokinetics to Participate in Upcoming Investor Conferences

Written by Customer Service on June 2, 2021. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., June 02, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in three virtual fireside chats at the following investor conferences:42nd Annual Goldman Sachs Healthcare Conference on Wednesday, June 9, 2021 at 3:00 PM EDT JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 4:00 PM EDT Raymond James Human Health Innovation Conference on Monday, June 21, 2021 at 2:00 PM EDTInterested parties may access the live webcasts of each presentation by visiting the Investors & Media section of the Cytokinetics website at www.cytokinetics.com. The replay of each presentation will be archived on the Presentations page within the Investors & Media section of Cytokinetics’...

Day: June 2, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals